Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PK Profile”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00503490
What this trial is testing

Safety, Pharmacokinetic and Pharmacodynamic Study of MP-376 in Patients With Cystic Fibrosis

Who this might be right for
Cystic Fibrosis
Amgen 40
Early research (Phase 1)Study completedNCT05332340
What this trial is testing

Safety, Tolerability and Pharmacokinetics (PK) Evaluation of BZ371A, Topically Administered

Who this might be right for
Erectile Dysfunction Following Radical ProstatectomyErectile DysfunctionProstate Cancer+1 more
Biozeus Biopharmaceutical S.A. 12
Testing effectiveness (Phase 2)Looking for participantsNCT07551804
What this trial is testing

Safety, Pharmacokinetic (PK) Profile and Efficacy of Inpegsomatropin Injection in Adults With Growth Hormone Deficiency

Who this might be right for
Adult Growth Hormone Deficiency
Xiamen Amoytop Biotech Co., Ltd. 36
Early research (Phase 1)Study completedNCT01476189
What this trial is testing

Compare to the Pharmacokinetic Profile of Two Paracetamol Formulations

Who this might be right for
Healthy Subjects
GlaxoSmithKline 28
Early research (Phase 1)Looking for participantsNCT07422610
What this trial is testing

Pharmacokinetics and Safety Study of Pelabresib in Patients With Advanced Malignancies and Hepatic Impairment

Who this might be right for
Advanced Malignancies and Hepatic Impairment
Novartis Pharmaceuticals 24
Early research (Phase 1)Study completedNCT03610880
What this trial is testing

To Evaluate PK and Safety Profile of Oral MAD of Separately Using TG-2349, DAG181 or Combination in Healthy Chinese Volunteers

Who this might be right for
Healthy Chinese Volunteers
Dongguan HEC TaiGen Biopharmaceuticals Co., Ltd. 24
Early research (Phase 1)Study completedNCT01610310
What this trial is testing

Peginterferon Beta-1a (BIIB017) Autoinjector Pharmacokinetic Study in Healthy Volunteers

Who this might be right for
HealthyMultiple Sclerosis
Biogen 55
Early research (Phase 1)Study completedNCT02033668
What this trial is testing

Pharmacokinetic (PK) Study of GSK933776 in Healthy Volunteers

Who this might be right for
Atrophy, Geographic
GlaxoSmithKline 36
Testing effectiveness (Phase 2)Study completedNCT00422786
What this trial is testing

Phase II Study of CAP-232 in Patients With Refractory Metastatic Renal Cell Carcinoma

Who this might be right for
Carcinoma, Renal Cell
Thallion Pharmaceuticals 10
Testing effectiveness (Phase 2)Study completedNCT00476853
What this trial is testing

Efficacy Safety Study Comparing 2 Doses of NVP After Initiating Rifampin-containing TB Therapy

Who this might be right for
HIV InfectionsTuberculosis
The HIV Netherlands Australia Thailand Research Collaboration 42
Early research (Phase 1)Study completedNCT01952561
What this trial is testing

Expanded Use PK of Dapivirine Vaginal Ring

Who this might be right for
Pharmacokinetics
International Partnership for Microbicides, Inc. 40
Early research (Phase 1)Study completedNCT04157933
What this trial is testing

Staccato Apomorphine Multi-dose PK and PD in Patients With Parkinson's Disease

Who this might be right for
Parkinson's Disease
Alexza Pharmaceuticals, Inc. 35
Early research (Phase 1)Study completedNCT01250730
What this trial is testing

A Study In Japanese Healthy Male Volunteers To Investigate The Safety, Tolerability And Pharmacokinetics Of PF-02341066

Who this might be right for
Healthy
Pfizer 18
Early research (Phase 1)UnknownNCT05863442
What this trial is testing

Comparative PK, Safety, Tolerability, Immunogenicity, and PD Profile Study of TUR03 and Soliris in Healthy Participants

Who this might be right for
Healthy
Turgut Ardika PTY LTD 120
Early research (Phase 1)Study completedNCT01222949
What this trial is testing

A Pharmacokinetic (PK) Trial in Healthy Asian and Caucasian Volunteers Investigating the PK Profile of Eurartesim™

Who this might be right for
Malaria, Falciparum
sigma-tau i.f.r. S.p.A. 80
Early research (Phase 1)Study completedNCT02398448
What this trial is testing

IVIVR Assessing PK Parameters Used to Establish Bioequivalence

Who this might be right for
Healthy
Ardea Biosciences, Inc. 20
Testing effectiveness (Phase 2)WithdrawnNCT05641298
What this trial is testing

Study to Determine the Efficacy&Safety of ARV-1801(ACG-701) for the Treatment of Cystic Fibrosis Pulmonary Exacerbations

Who this might be right for
Cystic FibrosisCystic Fibrosis Pulmonary Exacerbation
Aceragen
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06747416
What this trial is testing

KN057 Multiple Dose Study in Patients with Hemophilia a or Hemophilia B with or Without Inhibitors

Who this might be right for
Hemophilia a and B
Suzhou Alphamab Co., Ltd. 24
Early research (Phase 1)Study completedNCT01992211
What this trial is testing

Evaluating of Pharmacokinetic Profile of BCWP_C003 and Co-administration of Rosuvastatin and Metformin

Who this might be right for
Healthy
BC World Pharm Co. Ltd. 35
Early research (Phase 1)Study completedNCT02004587
What this trial is testing

Influence of Hepatic Impairment on Pharmacokinetic (PK) and Pharmacodynamic (PD) of Gemigliptin PK and PD After Multiple Oral Doses in Healthy White Volunteers

Who this might be right for
Hepatic Impairment
LG Life Sciences 28
Next Page